{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:57:26Z","timestamp":1781013446096,"version":"3.54.1"},"reference-count":20,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,8]]},"DOI":"10.31744\/einstein_journal\/2026gs1136","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:58:26Z","timestamp":1781009906000},"source":"Crossref","is-referenced-by-count":0,"title":["Rigid cystoscopy versus flexible outpatient cystoscopy: the economic cost behind the epidemiological and social impact"],"prefix":"10.31744","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9022-1880","authenticated-orcid":false,"given":"Guilherme Andrade","family":"Peixoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1973-4026","authenticated-orcid":false,"given":"Matheus Pascotto de","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-1382","authenticated-orcid":false,"suffix":"Junior","given":"Edson","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4261-4345","authenticated-orcid":false,"given":"Fernando","family":"Korkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"key":"key20260609125823_B1","author":"Ferlay","year":"2013","unstructured":"1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer; 2013 [cited 2026 Jan 8]. Available from: https:\/\/publications.iarc.who.int\/Databases\/Iarc-Cancerbases\/GLOBOCAN-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1.0-2012","journal-title":"Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012"},{"key":"key20260609125823_B2","author":"Human Development Reports","year":"2013","unstructured":"2. Human Development Reports. United Nations Development Programme. United Nations; 2013 [cited 2020 June 8]. Available from: http:\/\/hdr.undp.org\/en","journal-title":"United Nations Development Programme"},{"issue":"10","key":"key20260609125823_B3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamasurg.2018.1680","article-title":"Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer","volume":"153","author":"Williams","year":"2018","unstructured":"3. Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, et al. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer. JAMA Surg. 2018;153(10):881-9.","journal-title":"JAMA Surg"},{"issue":"3","key":"key20260609125823_B4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic Burden of Bladder Cancer Across the European Union","volume":"69","author":"Leal","year":"2016","unstructured":"4. Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA. Economic Burden of Bladder Cancer Across the European Union. Eur Urol. 2016;69(3):438-47.","journal-title":"Eur Urol"},{"issue":"3","key":"key20260609125823_B5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s41669-022-00325-7","article-title":"Stage-Related Cost of Treatment of Bladder Cancer in Brazil","volume":"6","author":"Korkes","year":"2022","unstructured":"5. Korkes F, Tim\u00f3teo F, Soledade LC, Bugalho LS, Peixoto GA, Teich VD, et al. Stage-Related Cost of Treatment of Bladder Cancer in Brazil. PharmacoEconom Open. 2022;6(3):461-8.","journal-title":"PharmacoEconom Open"},{"issue":"4","key":"key20260609125823_B6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.euo.2019.01.015","article-title":"The Cost to Medicare of Bladder Cancer Care","volume":"3","author":"Sloan","year":"2020","unstructured":"6. Sloan FA, Yashkin AP, Akushevich I, Inman BA. The Cost to Medicare of Bladder Cancer Care. Eur Urol Oncol. 2020;3(4):515-22.","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"key20260609125823_B7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: what are the benefits and costs?","volume":"27","author":"Sievert","year":"2009","unstructured":"7. Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, et al. Economic aspects of bladder cancer: what are the benefits and costs? World J Urol. 2009;27(3):295-300.","journal-title":"World J Urol"},{"key":"key20260609125823_B8","volume-title":"C\u00e2ncer no Brasil - A jornada do paciente no sistema de sa\u00fade e seus impactos sociais e financeiros","author":"Gaona","year":"2018","unstructured":"8. Gaona HJ, Carvalhaes E, Paletta N, Clark S, Simon S, Holtz L. C\u00e2ncer no Brasil - A jornada do paciente no sistema de sa\u00fade e seus impactos sociais e financeiros. S\u00e3o Paulo: Interfarma; 2018."},{"issue":"11","key":"key20260609125823_B9","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/cncr.21896","article-title":"Quality of life in long-term survivors of bladder cancer","volume":"106","author":"Allareddy","year":"2006","unstructured":"9. Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer. 2006;106(11):2355-62.","journal-title":"Cancer"},{"issue":"3","key":"key20260609125823_B10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.urology.2006.03.062","article-title":"Clinical model of lifetime cost of treating bladder cancer and associated complications","volume":"68","author":"Avritscher","year":"2006","unstructured":"10. Avritscher EB, Cooksley CD, Grossman HB, Sabichi AL, Hamblin L, Dinney CP, et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology. 2006;68(3):549-53.","journal-title":"Urology"},{"issue":"4","key":"key20260609125823_B11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1464-410X.2010.09912.x","article-title":"Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience","volume":"108","author":"Yafi","year":"2011","unstructured":"11. Yafi FA, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, et al. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int. 2011;108(4): 539-45.","journal-title":"BJU Int"},{"issue":"6","key":"key20260609125823_B12","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.juro.2012.01.077","article-title":"The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer","volume":"187","author":"Kim","year":"2012","unstructured":"12. Kim SP, Shah ND, Karnes RJ, Weight CJ, Frank I, Moriarty JP, et al. The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer. J Urol. 2012;187(6):2011-7.","journal-title":"J Urol"},{"issue":"2","key":"key20260609125823_B13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","unstructured":"13. Svatek RS, Hollenbeck BK, Holm\u00e4ng S, Lee R, Kim SP, Stenzl A, et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol. 2014;66(2):253-62.","journal-title":"Eur Urol"},{"issue":"2","key":"key20260609125823_B14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1590\/s1677-5538.ibju.2020.0658","article-title":"Increasing costs from bladder cancer in the Brazilian Health System: the role of establishing public health policies","volume":"47","author":"Korkes","year":"2021","unstructured":"14. Korkes F, Maluf F. Increasing costs from bladder cancer in the Brazilian Health System: the role of establishing public health policies. Int Braz J Urol. 2021;47(2):443-7.","journal-title":"Int Braz J Urol"},{"issue":"4","key":"key20260609125823_B15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bju.13154","article-title":"Long-term outcomes in a high-risk bladder cancer screening cohort","volume":"117","author":"Starke","year":"2016","unstructured":"15. Starke N, Singla N, Haddad A, Lotan Y. Long-term outcomes in a high-risk bladder cancer screening cohort. BJU Int. 2016;117(4):611-7.","journal-title":"BJU Int"},{"issue":"6","key":"key20260609125823_B16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/003655901753367613","article-title":"The results of routine evaluation of adult patients with haematuria analysed according to referral form information with 2-year follow-up","volume":"35","author":"Boman","year":"2001","unstructured":"16. Boman H, Hedelin H, Holm\u00e4ng S. The results of routine evaluation of adult patients with haematuria analysed according to referral form information with 2-year follow-up. Scand J Urol Nephrol. 2001;35(6):497-501.","journal-title":"Scand J Urol Nephrol"},{"issue":"4","key":"key20260609125823_B17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-5347(17)50594-7","article-title":"Flexible fiberoptic and rigid-rod lens endoscopy of the lower urinary tract: a prospective controlled comparison","volume":"131","author":"Clayman","year":"1984","unstructured":"17. Clayman RV, Reddy P, Lange PH. Flexible fiberoptic and rigid-rod lens endoscopy of the lower urinary tract: a prospective controlled comparison. J Urol. 1984 Apr;131(4):715-6.","journal-title":"J Urol"},{"issue":"4","key":"key20260609125823_B18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1464-410X.1993.tb16175.x","article-title":"Does flexible cystoscopy miss more tumours than rod-lens examination?","volume":"72","author":"Walker","year":"1993","unstructured":"18. Walker L, Liston TG, LLoyd-Davies RW. Does flexible cystoscopy miss more tumours than rod-lens examination? Br J Urol. 1993;72(4):449-50.","journal-title":"Br J Urol"},{"issue":"2","key":"key20260609125823_B19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1590\/s1677-5538.ibju.2019.0198","article-title":"Bladder cancer trends and mortality in the brazilian public health system","volume":"46","author":"Timoteo","year":"2020","unstructured":"19. Timoteo F, Korkes F, Baccaglini W, Glina S. Bladder cancer trends and mortality in the brazilian public health system. Int Braz J Urol. 2020;46(2):224-33.","journal-title":"Int Braz J Urol"},{"issue":"6","key":"key20260609125823_B20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update","volume":"86","author":"Gontero","year":"2024","unstructured":"20. Gontero P, Birtle A, Capoun O, Comp\u00e9rat E, Dominguez-Escrig JL, Liedberg F, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update. Eur Urol. 2024;86(6):531-49. Review.","journal-title":"Eur Urol"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:58:29Z","timestamp":1781009909000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/rigid-cystoscopy-versus-flexible-outpatient-cystoscopy-the-economic-cost-behind-the-epidemiological-and-social-impact\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"alternative-id":["10.31744\/einstein_journal\/2026GS1136"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2026gs1136","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"eGS1136"}}